David Chernoff, MD
Chief Medical Officer
Dr. David Chernoff heads the Pulse Health Science Advisory Board and serves as the company’s chief medical officer. He combines the perspective of a practicing clinician with decades of biopharma industry experience. As medical director of research and development at Chiron Diagnostics, Dr. David Chernoff played a pivotal role in the development of assays for HIV, HCV, HBV and CMV. At Elan Pharmaceutical Management Corporation he served as VP of corporate technology and led the evaluation of a broad range of in-licensing opportunities.
Raymond Akers, PhD
CEO, Akers Biosciences
Dr. Raymond Akers is a leading inventor of diagnostic tools, including rapid testing for cholesterol, DNA and alcohol. With more than 25 years in the medical diagnostic industry, Dr. Raymond Akers has founded or co-founded three companies. His current venture, Akers Biosciences, has been selected by major pharmaceuticals, such as Pfizer, to create their diagnostics.
Peter Barnes, PhD
National Heart & Lung Institute, Imperial College of London
Dr. Peter Barnes has done extensive study on exhaled breath condensate (EBC) and is a member of the EBC Taskforce. Dr. Peter Barnes holds patents in the UK for methods of diagnosing, monitoring and treating pulmonary disease. He was elected a Fellow of the Royal Society in 2007, and he is the first respiratory researcher to be elected to that post in more than 150 years
Garry Buettner, PhD
Professor University of Iowa
Dr. Garry Buettner has more than 20 years of experience with nearly all aspects of CW-EPR, or continuous wave EPR spectroscopy. He is considered a national leader in free radical chemistry. In 2008, he was recognized as a Fellow of the American Association for the Advancement of Science for his contributions and leadership in the field of free radical biology, and he is a past president of the Society for Free Radical Biology and Medicine.
Massimo Corradi, MD
University of Parma, Italy
Dr. Massimo Corradi is recognized as the world leader in analyzed aldehydes in breath and is considered the world leader in research on chronic obstructive pulmonary disease. He is the foremost expert in this area on the international Exhaled Breath Condensate (EBC) Taskforce.
Ruthie Harper, MD
Founder, Nutritional Medicine Associates
Dr. Ruthie Harper is a top expert in the formulation of scientifically proven nutritional compounds. A board certified internist, Dr. Ruthie Harper founded her own health and wellness practice in 1999. Her approach toward achieving optimal health is based on basic biochemistry and cellular science.
John Hunt, MD
Pediatric Respiratory Medicine, University of Virginia
Dr. John Hunt’s research on pediatric lung disease has led to the development of several inventions that can be used to diagnose and monitor asthma and other lung diseases in simple, accurate and noninvasive ways.
Steven Mastin, PhD
Chief Science Officer
Dr. Steven Mastin is a leading expert in the development and science behind advanced diagnostics, as well as intellectual property protection associated with such development. With more than 25 years of experience in all areas of the biomedical industry, Dr. Steven Mastin has developed numerous clinical assays, including a widely accepted free radical test.
Sharron Gargosky, PhD
Chief Scientific Officer
Dr. Sharron Gargosky is chief scientific officer for Pulse Health, leading technology and scientific strategy for the company. Dr. Sharron Gargosky has more than 15 years of experience in academic and corporate venues, and she joins Pulse Health from Hyperion Therapeutics Inc., where she served as chief scientific officer and senior vice president of corporate development. Previously, she was executive director of research and development with Medicis/Ucyclyd Pharma. She holds a PhD from the University of Adelaide in South Australia and completed a postdoctoral fellowship in pediatric endocrinology at Stanford University.